𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Transient trisomy 8 abnormality in Philadelphia-negative cells during imatinib mesylate treatment of chronic myelogenous leukemia

✍ Scribed by M. KIM; S. LEE; C. K. JUNG; J. LIM; S. G. CHO; D. W. KIM; Y. KIM; K. HAN; W. S. MIN; C. C. KIM

Book ID
111415070
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
54 KB
Volume
0
Category
Article
ISSN
1751-5521

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Chromosomal abnormalities in Philadelphi
Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase
✍ Jorge Medina; Hagop Kantarjian; Moshe Talpaz; Susan O'Brien; Guillermo Garcia-Ma πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 107 KB

## Abstract ## BACKGROUND Anecdotal cases of chromosomal abnormalities in Philadelphia chromosome (Ph)‐negative metaphases have been reported in patients with chronic myelogenous leukemia (CML) in the chronic phase during treatment with interferon and, more recently, with imatinib. This phenomenon

P107 Chromosomal abnormalities in Philad
P107 Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome positive chronic myeloid leukemia in chronic phase
✍ S. Jootar πŸ“‚ Article πŸ“… 2007 πŸ› Elsevier Science 🌐 English βš– 51 KB

6/155), high white cell number (13/155) (red cell unit) or low thrombocyte number (14/125) (thrombocyte unit). Summary: Donors with low hemoglobin levels have to be excluded from the blood donation service for 3 months. So, in theory haemoglobin concentration of all total blood units is suitable for